MedPath

The effects of Suvorexant, a novel orexin receptor antagonist, on physical and cognitive functions after nocturnal forced-awakening

Not Applicable
Conditions
Insomnia
Registration Number
JPRN-UMIN000022752
Lead Sponsor
niversity of Tsukuba Faculty of health and sport sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Male
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

1)Participants who are taking a pill to inhibit CYP3A 2)Acute angle crose glaucoma 3)Myasthenia gravis

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath